Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT Trial)

NCT00574847 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00574847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00574847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT Trial)
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2006
Completion date
November 30, 2011
Enrollment
127 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial ischemia